Moral and Contextual Dimensions of "Inappropriate" Antibiotic Prescribing in Secondary Care: A Three-Country Interview Study.

antibiotic prescribing antimicrobial resistance hospital international qualitative investigation

Journal

Frontiers in sociology
ISSN: 2297-7775
Titre abrégé: Front Sociol
Pays: Switzerland
ID NLM: 101777459

Informations de publication

Date de publication:
2020
Historique:
received: 31 10 2019
accepted: 04 02 2020
entrez: 19 4 2021
pubmed: 20 2 2020
medline: 20 2 2020
Statut: epublish

Résumé

Overuse of broad-spectrum antibiotics in secondary care is a key contributor to the emergence and spread of antimicrobial resistance (AMR); efforts are focused on minimizing antibiotic overuse as a crucial step toward containing the global threat of AMR. The concept of overtreatment has, however, been difficult to define. Efforts to address the overuse of medicine need to be informed by an understanding of how prescribers themselves understand the problem. We report findings from a qualitative interview study of 46 acute care hospital prescribers differing in seniority from three countries: United Kingdom, Sri Lanka and South Africa. Prescribers were asked about their understanding of inappropriate use of antibiotics. Prescriber definitions of inappropriate use included relatively clear-cut and unambiguous cases of antibiotics being used "incorrectly" (e.g., in the case of viral infections). In many cases, however, antibiotic prescribing decisions were seen as involving uncertainty, with prescribers having to make decisions about the threshold for appropriate use. Decisions about thresholds were commonly framed in moral terms. Some prescribers drew on arguments about their duty to protect public health through having a high threshold for prescribing, while others made strong arguments for prioritizing risk avoidance for the patients in front of them, even at a cost of increased resistance. Notions of whether prescribing was inappropriate were also contextually dependent: high levels of antibiotic prescribing could be seen as a rational response when prescribers were working in challenging contexts, and could be justified in relation to financial and social considerations. Inappropriate antibiotic use is framed by prescribers not just in clinical, but also in moral and contextual terms; this has implications for the design and implementation of antibiotic stewardship interventions aiming to reduce inappropriate use of antibiotics globally.

Identifiants

pubmed: 33869416
doi: 10.3389/fsoc.2020.00007
pmc: PMC8022648
doi:

Types de publication

Journal Article

Langues

eng

Pagination

7

Informations de copyright

Copyright © 2020 Tarrant, Krockow, Nakkawita, Bolscher, Colman, Chattoe-Brown, Perera, Mehtar and Jenkins.

Références

Soc Sci Med. 2006 Mar;62(5):1078-90
pubmed: 16233942
J Hosp Infect. 2019 Apr;101(4):428-439
pubmed: 30099092
Qual Saf Health Care. 2007 Apr;16(2):143-9
pubmed: 17403764
BMJ Glob Health. 2019 Aug 15;4(4):e001590
pubmed: 31497315
Crit Care. 2016 Jun 22;20(1):136
pubmed: 27329228
J Antimicrob Chemother. 2011 Feb;66(2):443-9
pubmed: 21084362
Clin Infect Dis. 2016 Dec 15;63(12):1639-1644
pubmed: 27682070
PLoS Med. 2019 Mar 29;16(3):e1002774
pubmed: 30925166
Ann Pharmacother. 2016 Mar;50(3):172-9
pubmed: 26783358
Front Pharmacol. 2017 Nov 09;8:751
pubmed: 29163151
Qual Saf Health Care. 2010 Dec;19(6):e8
pubmed: 20595720
N Engl J Med. 1993 Oct 21;329(17):1268-71
pubmed: 8123111
Clin Microbiol Infect. 2017 Nov;23(11):812-818
pubmed: 28712667
Clin Microbiol Infect. 2017 Nov;23(11):799-805
pubmed: 28750920
J Antimicrob Chemother. 2012 Jan;67(1):12-6
pubmed: 21980065
J Antimicrob Chemother. 2011 Nov;66(11):2441-3
pubmed: 21926080
PLoS One. 2019 Jan 16;14(1):e0209847
pubmed: 30650099
Antimicrob Resist Infect Control. 2019 Feb 12;8:35
pubmed: 30805182
Antibiotics (Basel). 2018 Dec 22;8(1):
pubmed: 30583566
Clin Microbiol Infect. 2019 Nov;25(11):1356-1363
pubmed: 30910716
Lancet Infect Dis. 2010 Mar;10(3):167-75
pubmed: 20185095
BMJ Qual Saf. 2019 Sep;28(9):758-761
pubmed: 31018985
Soc Sci Med. 2001 Sep;53(5):657-67
pubmed: 11478544
Cochrane Database Syst Rev. 2017 Feb 09;2:CD003543
pubmed: 28178770
Antibiotics (Basel). 2019 Apr 29;8(2):
pubmed: 31035663

Auteurs

Carolyn Tarrant (C)

Department of Health Sciences, University of Leicester, Leicester, United Kingdom.

Eva M Krockow (EM)

Department of Neuroscience, Psychology and Behaviour, University of Leicester, Leicester, United Kingdom.

W M I Dilini Nakkawita (WMID)

Faculty of Medicine, General Sir John Kotelawala Defence University, Colombo, Sri Lanka.

Michele Bolscher (M)

Tygerberg Academic Hospital and Faculty of Health Sciences, Stellenbosch University, Cape Town, South Africa.

Andrew M Colman (AM)

Department of Neuroscience, Psychology and Behaviour, University of Leicester, Leicester, United Kingdom.

Edmund Chattoe-Brown (E)

School of Media, Communication and Sociology, University of Leicester, Leicester, United Kingdom.

Nelun Perera (N)

Department of Clinical Microbiology, University Hospitals of Leicester NHS Trust, Leicester, United Kingdom.

Shaheen Mehtar (S)

Tygerberg Academic Hospital and Faculty of Health Sciences, Stellenbosch University, Cape Town, South Africa.

David R Jenkins (DR)

Department of Clinical Microbiology, University Hospitals of Leicester NHS Trust, Leicester, United Kingdom.

Classifications MeSH